This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.
The drug LUVERIS contains one active pharmaceutical ingredient (API):
1
|
UNII
3JGY52XJNA - LUTROPIN ALFA
|
|
Lutropin alfa is a recombinant human Luteinising Hormone (r-hLH). Luteinising Hormone (LH) binds on the ovarian theca (and granulosa) cells and testicular Leydig cells, to a receptor shared with human chorionic gonadotropin hormone (hCG). Lutropin alfa in association with a Follicle Stimulating Hormone (FSH) preparation is recommended for the stimulation of follicular development in adult women with severe Luteinising Hormone (LH) and FSH deficiency. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LUVERIS Powder and solvent for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G03G | Gonadotropins and other ovulation stimulants | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system |
| G03GA07 | Lutropin alfa | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 10465T |
| BR | Câmara de Regulação do Mercado de Medicamentos | 525421001159413 |
| CA | Health Products and Food Branch | 02269066 |
| EE | Ravimiamet | 1046810, 1046821, 1046832 |
| ES | Centro de información online de medicamentos de la AEMPS | 00155006 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 100305 |
| FR | Base de données publique des médicaments | 66457697 |
| GB | Medicines & Healthcare Products Regulatory Agency | 45782 |
| HK | Department of Health Drug Office | 49706 |
| IE | Health Products Regulatory Authority | 88440, 89083 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 6539 |
| IT | Agenzia del Farmaco | 034951018, 034951020, 034951032, 034951044, 034951057, 034951069, 034951071 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1007415, 1008540, 1008541, 1029640, 1029641, 1029663 |
| NL | Z-Index G-Standaard | 14661098 |
| NL | Z-Index G-Standaard, PRK | 59099 |
| NZ | Medicines and Medical Devices Safety Authority | 10687 |
| PL | Rejestru Produktów Leczniczych | 100113238 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W65137001, W65137002, W65137003, W65137004, W65137005, W65137006 |
| SG | Health Sciences Authority | 12507P |
| TN | Direction de la Pharmacie et du Médicament | 22073021 |
| ZA | Health Products Regulatory Authority | 37/21.10/0560 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.